Structure-activity relationship for the folding intermediate-selective inhibition of DYRK1A

被引:5
|
作者
Miyazaki, Yuka [1 ]
Kikuchi, Masaki [2 ]
Umezawa, Koji [3 ]
Descamps, Aurelie [4 ]
Nakamura, Daichi [4 ]
Furuie, Gaku [1 ]
Sumida, Tomoe [4 ,6 ]
Saito, Kanako [1 ]
Kimura, Ninako [1 ]
Niwa, Takashi [4 ]
Sumida, Yuto [4 ,6 ]
Umehara, Takashi [2 ]
Hosoya, Takamitsu [4 ,5 ]
Kii, Isao [1 ,3 ,4 ]
机构
[1] Shinshu Univ, Grad Sch Sci & Technol, Dept Agr, Lab Drug Target Res, 8304 Minami Minowa, Nagano 3994598, Japan
[2] RIKEN, Lab Epigenet Drug Discovery, Ctr Biosyst Dynam Res, Tsurumi Ku, 1-7-22 Suehiro Cho, Yokohama, Kanagawa 2300045, Japan
[3] Shinshu Univ, Inst Biomed Sci, Dept Biomol Innovat, 8304 Minami Minowa, Nagano 3994598, Japan
[4] RIKEN, Lab Chem Biol, Ctr Biosyst Dynam Res, Chuo Ku, 6-7-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan
[5] Tokyo Med & Dent Univ TMDU, Inst Biomat & Bioengn, Lab Chem Biosci, Chiyoda Ku, 2-3-10 Kanda Surugadai, Tokyo, Japan
[6] Kanazawa Univ, Grad Sch Med Sci, Div Pharmaceut Sci, Kakuma Machi, Kanazawa, Ishikawa 9201192, Japan
关键词
DYRK1A; Folding intermediate; Autophosphorylation; FINDY; Alzheimer's disease; Down syndrome; DOWN-SYNDROME CANDIDATE; PROTEIN-KINASE; MOUSE MODEL; MURINE MODEL; DRUG-TARGET; CYCLIN D1; ACTIVATION; AUTOPHOSPHORYLATION; OVEREXPRESSION; REVEALS;
D O I
10.1016/j.ejmech.2021.113948
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
DYRK1A phosphorylates proteins involved in neurological disorders in an intermolecular manner. Meanwhile, during the protein folding process of DYRK1A, a transitional folding intermediate catalyzes the intramolecular autophosphorylation required for the "one-off" inceptive activation and stabilization. In our previous study, a small molecule termed FINDY (1) was identified, which inhibits the folding intermediate-catalyzed intramolecular autophosphorylation of DYRK1A but not the folded state-catalyzed intermolecular phosphorylation. However, the structural features of FINDY (1) responsible for this intermediate-selective inhibition remain elusive. In this study, structural derivatives of FINDY (1) were designed and synthesized according to its predicted binding mode in the ATP pocket of DYRK1A. Quantitative structure-activity relationship (QSAR) of the derivatives revealed that the selectivity against the folding intermediate is determined by steric hindrance between the bulky hydrophobic moiety of the derivatives and the entrance to the pocket. In addition, a potent derivative 3 was identified, which inhibited the folding intermediate more strongly than FINDY (1); it was designated as dp-FINDY. Although dp-FINDY (3) did not inhibit the folded state, as well as FINDY (1), it inhibited the intramolecular autophosphorylation of DYRK1A in an in vitro cell-free protein synthesis assay. Furthermore, dp-FINDY (3) destabilized endogenous DYRK1A in HEK293 cells. This study provides structural insights into the folding intermediate-selective inhibition of DYRK1A and expands the chemical options for the design of a kinase inhibitor. (C) 2021 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:18
相关论文
共 50 条
  • [41] Structure-activity relationship of norzoanthamine exhibiting significant inhibition of osteoporosis
    Kuramoto, M
    Hayashi, K
    Yamaguchi, K
    Yada, M
    Tsuji, T
    Uemura, D
    BULLETIN OF THE CHEMICAL SOCIETY OF JAPAN, 1998, 71 (04) : 771 - 779
  • [42] Quantitative structure-activity relationship study of novel α1a-selective adrenoceptor antagonists
    Singh, P
    Kumar, R
    JOURNAL OF ENZYME INHIBITION, 2001, 16 (04): : 331 - 338
  • [43] STRUCTURE-ACTIVITY RELATIONSHIP OF PHENYLETHANOID GLYCOSIDES ON THE INHIBITION OF AMYLOID β AGGREGATION
    Kidachi, Eri
    Kurisu, Manami
    Miyamae, Yusaku
    Hanaki, Mizuho
    Murakami, Kazuma
    Irie, Kazuhiro
    Shigemori, Hideyuki
    HETEROCYCLES, 2016, 92 (11) : 1976 - 1982
  • [44] Computer analysis of structure-activity relationship for selective and nonselective inhibitors of cyclooxygenases 1 and 2
    Khairullina V.R.
    Mukhametov A.D.
    Garifullina G.G.
    Gerchikov A.Ya.
    Tyurina L.A.
    Zarudii F.S.
    Pharmaceutical Chemistry Journal, 2007, 41 (4) : 216 - 221
  • [45] INHIBITION OF IODOTHYRONINE 5'-DEIODINASE BY THIOUREYLENES - STRUCTURE-ACTIVITY RELATIONSHIP
    VISSER, TJ
    VANOVERMEEREN, E
    FEKKES, D
    DOCTER, R
    HENNEMANN, G
    FEBS LETTERS, 1979, 103 (02) : 314 - 318
  • [46] Inhibition of flavonoids on acetylcholine esterase: binding and structure-activity relationship
    Xie, Yixi
    Yang, Weijie
    Chen, Xiaoqing
    Xiao, Jianbo
    FOOD & FUNCTION, 2014, 5 (10) : 2582 - 2589
  • [47] Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
    Yasushi Ogawa
    Yosuke Nonaka
    Toshiyasu Goto
    Eriko Ohnishi
    Toshiyuki Hiramatsu
    Isao Kii
    Miyo Yoshida
    Teikichi Ikura
    Hiroshi Onogi
    Hiroshi Shibuya
    Takamitsu Hosoya
    Nobutoshi Ito
    Masatoshi Hagiwara
    Nature Communications, 1
  • [48] Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
    Ogawa, Yasushi
    Nonaka, Yosuke
    Goto, Toshiyasu
    Ohnishi, Eriko
    Hiramatsu, Toshiyuki
    Kii, Isao
    Yoshida, Miyo
    Ikura, Teikichi
    Onogi, Hiroshi
    Shibuya, Hiroshi
    Hosoya, Takamitsu
    Ito, Nobutoshi
    Hagiwara, Masatoshi
    NATURE COMMUNICATIONS, 2010, 1
  • [49] Inhibition of DYRK1A disrupts neural lineage specificationin human pluripotent stem cells
    Bellmaine, Stephanie F.
    Ovchinnikov, Dmitry A.
    Manallack, David T.
    Cuddy, Claire E.
    Elefanty, Andrew G.
    Stanley, Edouard G.
    Wolvetang, Ernst J.
    Williams, Spencer J.
    Pera, Martin
    ELIFE, 2017, 6
  • [50] Inhibition of DYRK1A and GSK3B induces human β-cell proliferation
    Weijun Shen
    Brandon Taylor
    Qihui Jin
    Van Nguyen-Tran
    Shelly Meeusen
    You-Qing Zhang
    Anwesh Kamireddy
    Austin Swafford
    Andrew F. Powers
    John Walker
    John Lamb
    Badry Bursalaya
    Michael DiDonato
    George Harb
    Minhua Qiu
    Christophe M. Filippi
    Lisa Deaton
    Carolina N. Turk
    Wilma L. Suarez-Pinzon
    Yahu Liu
    Xueshi Hao
    Tingting Mo
    Shanshan Yan
    Jing Li
    Ann E. Herman
    Bernhard J. Hering
    Tom Wu
    H. Martin Seidel
    Peter McNamara
    Richard Glynne
    Bryan Laffitte
    Nature Communications, 6